2024/08/16 17:31:02 | |
---|---|
Price | |
1.10 CHF | |
Difference | 0.00% (0.00) |
ISIN | CH1251125998 |
Symbol | RLF |
Exchange | SIX Swiss Exchange |
Currency | CHF |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 13 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | 1.10 CHF (2,905) |
Ask (Ask size) | 1.13 CHF (655) |
Open | 1.13 CHF |
High | 1.13 CHF |
Low | 1.10 CHF |
Close (prev. day) | 1.10 CHF |
VWAP | 1.100208 CHF |
Volume (pcs) | 4,304 |
Trading volume | 4,735.30 |
Number of trades | 17 |
Last size | - |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/08/12 |
![]() |
Global Equity Ratings |
![]() |
2024/07/12 |
![]() |
Global Equity Ratings |
![]() |
2024/07/03 |
![]() |
Global Strategy 3Q 2024 |
![]() |
2024/06/21 |
![]() |
Global Equity Ratings |
![]() |
2024/03/26 |
![]() |
Global Strategy 2Q 2024 |
![]() |
2024/08/16 17:31:02 | |
---|---|
Price | |
1.10 CHF | |
Difference | 0.00% (0.00) |
ISIN | CH1251125998 |
Symbol | RLF |
Exchange | SIX Swiss Exchange |
Currency | CHF |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 13 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | 1.10 CHF (2,905) |
Ask (Ask size) | 1.13 CHF (655) |
Open | 1.13 CHF |
High | 1.13 CHF |
Low | 1.10 CHF |
Close (prev. day) | 1.10 CHF |
VWAP | 1.100208 CHF |
Volume (pcs) | 4,304 |
Trading volume | 4,735.30 |
Number of trades | 17 |
Last size | - |
6m | 1Y | 3Y | |
Perf (%) | -35.29% | -51.75% | -98.57% |
Perf (abs.) | -0.60 | -1.18 | -75.70 |
Beta | 0.27 | 0.20 | 0.57 |
Volatility | 48.69 | 62.51 | 78.50 |
Ø price 5 days | Ø volume 5 days (pcs.) | 1.10 CHF (3,995) |
Ø price 30 days | Ø volume 30 days (pcs.) | 1.14 CHF (7,869) |
Ø price 100 days | Ø volume 100 days (pcs.) | 1.22 CHF (12,568) |
Ø price 250 days | Ø volume 250 days (pcs.) | 1.66 CHF (16,707) |
YTD High | date | 1.99 CHF (2024/01/03) |
YTD Low | date | 1.10 CHF (2024/06/19) |
52 Weeks High | date | 4.89 CHF (2023/09/01) |
52 Weeks Low | date | 1.10 CHF (2024/06/19) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
SIX Swiss Exchange | 2024/08/16 | 17:31 | 1.10 CHF | 0.00 | 17 |
London Stock Exchange | 2023/09/01 | 17:46 | 4.1412 CHF | 0.02 | 1 |
FINRA other OTC Issues | 2024/08/15 | 21:03 | 1.35 USD | 0.00 | 16 |
Berlin | 2019/06/28 | 15:58 | 0.08 EUR | 0.00 | 4 |
RELIEF THERAPEUTICS HOLDING SA |
- - |
Avenue de Sécheron 15 - 1202 Genf |
Telefon: +41-22-545-11-16 |
Fax: + |
E-mail: contact@relieftherapeutics.com |
RELIEF THERAPEUTICS Holding SA is a commercial-stage biopharmaceutical company, which engages in the research, development, and commercialization of treatment for rare debilitating conditions. The firm offers Physiomimic and TEHCLO, drug delivery platform technologies and a targeted clinical development pipeline consisting of risk-mitigated assets to address rare metabolic disorders, rare skin diseases, and rare respiratory diseases. It operates through the following geographical segments: Switzerland, Europe, North America, and Rest of the World. The company was founded in 2013 and is headquartered in Geneva, Switzerland. |
Andrew Einhorn | Member of Executive Committee |
Anthony Kim | Member of Executive Committee |
Giorgio Reiner | Member of Executive Committee |
Melinda Keegan | Member of Executive Committee |
Paolo Galfetti | Member of Executive Committee |
Vincenzo Gallo | Member of Executive Committee |
Gregory Van Beek | Member of the administrative board |
Peter Egon de Svastich | Member of the administrative board |
Tommy Elzinga | Member of the administrative board |
Raghuram Selvaraju | Chairman of the administrative boar |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer